• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Krystal Biotech, Inc. - Common Stock (NQ:KRYS)

    351.46 -6.00 (-1.68%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 143,506
    Open 356.92
    Bid (Size) 351.46 (240)
    Ask (Size) 351.84 (120)
    Prev. Close 357.46
    Today's Range 348.57 - 356.92
    52wk Range 136.73 - 382.54
    Shares Outstanding 22,205,642
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Here’s How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years ↗
    Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 32.97% on an annualized basis producing an average annual return of 44.08%. Currently, Krystal Biotech has a market... 
    Via Benzinga
    Krystal Biotech (NASDAQ:KRYS) Clears Minervini Trend Template and High Growth Momentum Screen ↗
    Via Chartmill

    Performance

    YTD
    +42.3%
    +42.3%
    1 Month
    -3.5%
    -3.5%
    3 Month
    +13.3%
    +13.3%
    6 Month
    +27.2%
    +27.2%
    1 Year
    +138.1%
    +138.1%

    More News

    Read More
    News headline image
    Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More ↗
    Via The Motley Fool
    News headline image
    Krystal Biotech (KRYS) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Krystal Biotech (NASDAQ:KRYS) Slips After Q2 Revenue Miss Despite EPS Beat ↗
    Via Chartmill
    Krystal Biotech (NASDAQ:KRYS) Shows High-Growth Momentum With Perfect Minervini Trend Template Setup ↗
    Via Chartmill
    Krystal Biotech (NASDAQ:KRYS) Combines Perfect Trend Template with High-Growth Momentum ↗
    Via Chartmill
    News headline image
    Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
    From Biotech Insider
    Via GlobeNewswire
    News headline image
    If You Invested $1000 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today ↗
    Via Benzinga
    News headline image
    Krystal Biotech Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    Krystal Biotech (NASDAQ:KRYS) Surges After Q1 Beat as VYJUVEK Revenue Hits $116.4M ↗
    Via Chartmill
    News headline image
    These 3 Healthcare Stocks Have Crushed the Market This Year. Here's Why There's More Upside Ahead ↗
    Via The Motley Fool
    Topics Economy
    News headline image
    Why Tutor Perini Stock Trounced the Market on Tuesday ↗
    Via The Motley Fool
    Topics Stocks
    News headline image
    3 Soaring Stocks That May Have More Upside Ahead ↗
    Via The Motley Fool
    News headline image
    3 Biotech Firms With Major Potential Catalysts in the Coming Months ↗
    Via MarketBeat
    Topics Intellectual Property
    News headline image
    These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead ↗
    Via The Motley Fool
    News headline image
    Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why This Tech Fund Made a $5.8 Million Bet on an AI Chip Stock Up Nearly 200% Post-IPO ↗
    Via The Motley Fool
    Topics Artificial Intelligence Initial Public Offering Regulatory Compliance
    News headline image
    This AI Semiconductor Stock Beat the S&P 500 by 9 Points. A Fund Just Exited Completely ↗
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance Stocks
    News headline image
    Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug ↗
    Via The Motley Fool
    News headline image
    Krystal (KRYS) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Krystal (KRYS) Q1 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Is Paymentus Stock a Buy After Palisades Investment Partners Increased Its Stake By $6 Million? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Is Amprius Technologies Stock a Buy After Palisades Investment Partners Initiated a Position Worth $4.8 Million? ↗
    Via The Motley Fool
    Topics Electric Vehicles Regulatory Compliance

    Frequently Asked Questions

    Is Krystal Biotech, Inc. - Common Stock publicly traded?
    Yes, Krystal Biotech, Inc. - Common Stock is publicly traded.
    What exchange does Krystal Biotech, Inc. - Common Stock trade on?
    Krystal Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Krystal Biotech, Inc. - Common Stock?
    The ticker symbol for Krystal Biotech, Inc. - Common Stock is KRYS on the Nasdaq Stock Market
    What is the current price of Krystal Biotech, Inc. - Common Stock?
    The current price of Krystal Biotech, Inc. - Common Stock is 351.46
    When was Krystal Biotech, Inc. - Common Stock last traded?
    The last trade of Krystal Biotech, Inc. - Common Stock was at 08/28/26 04:00 PM ET
    What is the market capitalization of Krystal Biotech, Inc. - Common Stock?
    The market capitalization of Krystal Biotech, Inc. - Common Stock is 7.80B
    How many shares of Krystal Biotech, Inc. - Common Stock are outstanding?
    Krystal Biotech, Inc. - Common Stock has 8B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.